PortViewPortView
INVO Bioscience logo

INVO Bioscience (INVO) Stock Analysis

NASDAQHealthcareMedical - Devices

$0.83-2.00%
1-year price historyRange $0.66 – $2.08
52-week range$0.83
$0.63$3.50

What INVO Bioscience does

INVO Bioscience, Inc. is a globally operating, commercial-phase enterprise focused on fertility, offering advanced solutions in assisted reproductive technology. Their leading product is the INVOcell, an innovative medical device engineered to allow fertilization and the initial development of embryos to naturally occur inside the woman's body. The company, headquartered in Sarasota, Florida, began its operations in 2007.

Key metrics

Market cap
$3.25M
P/E (TTM)
1.21
EPS (TTM)
$0.69
Beta
1.44
Dividend yield
0.00%
Revenue / share
$3.58
50-day avg
$0.77
200-day avg
$0.90
52-week high
$3.50
52-week low
$0.63
CEO
Steven M. Shum

ETFs linked to INVO

Broad-market and Healthcare sector ETFs an investor holding INVO Bioscience is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how INVO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze INVO in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for INVO Bioscience?
INVO Bioscience trades under the ticker INVO on NASDAQ.
Which exchange is INVO listed on?
INVO is listed on NASDAQ.
What sector does INVO Bioscience operate in?
INVO Bioscience is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze INVO in a portfolio?
PortView shows INVO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.